Alivira Animal Health (Alivira), a wholly owned subsidiary of SeQuent Scientific (SeQuent) has received United States Food and Drug Administration (USFDA) approval for its Animal Health API facility at Visakhapatnam, Andhra Pradesh. This 225KL capacity multi-product facility at Vizag was inspected for the first time by USFDA in November 2016 and has now received Establishment Inspection Report (EIR) from US FDA. The receipt of the EIR will enable Alivira’s entry into $8 billion US veterinary healthcare market.
Alivira is the largest animal health company from India with annual revenues of $120 million. It is also the largest animal health API manufacturer from India. Predominant in anthelmintic, the company has 16 products in the primary therapies across antibiotics, beta agonists, NSAID, antiprotozoal and feed additives. Over the last year, the Company has launched five new products and filed for 6 Veterinary Master Files (VMF). The Company also has a pipeline of over seven products at different stages at development.